Merck (MRK) Enterprise Value (2009 - 2026)

Merck has disclosed Enterprise Value across 18 years of filings, most recently posting -$5.6 billion for Q1 2026.

• In Q1 2026, Enterprise Value rose 38.35% year-over-year to -$5.6 billion; the TTM figure through Mar 2026 stood at -$5.6 billion (up 38.35% YoY), while the FY2025 annual figure was -$14.5 billion, down 6.45% from the prior year.
• Enterprise Value grew to -$5.6 billion in Q1 2026, from -$14.5 billion in the prior quarter.
• Over the last five years, Enterprise Value for MRK reached as high as -$5.6 billion in Q1 2024 and fell as low as -$18.2 billion in Q3 2025.
• The 5-year median for Enterprise Value is -$10.1 billion (2022), against an average of -$10.4 billion.
• Annual changes were most pronounced in 2023 — Enterprise Value jumped 46.37% — and 2024, when it plunged 93.64%.
• A 5-year view of Enterprise Value shows it stood at -$13.1 billion in 2022, then soared by 46.37% to -$7.0 billion in 2023, then sank by 93.64% to -$13.6 billion in 2024, then fell by 6.45% to -$14.5 billion in 2025, then soared by 61.07% to -$5.6 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$5.6 billion, -$14.5 billion, and -$18.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.